英文摘要 |
With the advancement of medical technology, the public demand for medical services is no longer limited to traditional disease treatment, but has begun to expand to personalized precision medicine and toward precision health, so the demand for personalized testing services has also flourished. Compared with traditional testing, precision medicine molecular testing is relatively complex with a wider range of analytical scopes and highly sophisticated instruments are often needed to process data through complex statistical models. The associated risks thus increased accordingly. Therefore, quality management system of laboratory must also keep pace with the times. In order to improve the quality of Taiwan’s precision medicine molecular testing laboratory testing and services, the Food and Drug Administration of the Ministry of Health and Welfare announced the “Guidelines for Registration and Monitoring of Laboratory Developed Test and Service for Precision Medicine Molecular Testing” on December 17, 2017, and conducted the registration of precision medicine molecular testing ever since. This study surveyed the cases related to the registration of precision medicine molecular testing laboratories from 2019 to 2021, and reviewed the testing items provided by the laboratories. The classification of technology is dominated by next-generation sequencing (49.5%), and its service area is mainly classified as somatic mutation or germline mutation, each accounting for 37.5%. It is found via on-site inspections that the most common nonconformity cases were related to “skills requirements”, “quality requirements” and “personnel and equipment requirements”, indicating that the quality management systems of relevant laboratories are taking shape. |